These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 17060315)
1. Expression of claudin7 is tightly associated with epithelial structures in synovial sarcomas and regulated by an Ets family transcription factor, ELF3. Kohno Y; Okamoto T; Ishibe T; Nagayama S; Shima Y; Nishijo K; Shibata KR; Fukiage K; Otsuka S; Uejima D; Araki N; Naka N; Nakashima Y; Aoyama T; Nakayama T; Nakamura T; Toguchida J J Biol Chem; 2006 Dec; 281(50):38941-50. PubMed ID: 17060315 [TBL] [Abstract][Full Text] [Related]
2. Expression profiling of synovial sarcoma by cDNA microarrays: association of ERBB2, IGFBP2, and ELF3 with epithelial differentiation. Allander SV; Illei PB; Chen Y; Antonescu CR; Bittner M; Ladanyi M; Meltzer PS Am J Pathol; 2002 Nov; 161(5):1587-95. PubMed ID: 12414507 [TBL] [Abstract][Full Text] [Related]
3. E-cadherin mutation and Snail overexpression as alternative mechanisms of E-cadherin inactivation in synovial sarcoma. Saito T; Oda Y; Kawaguchi K; Sugimachi K; Yamamoto H; Tateishi N; Tanaka K; Matsuda S; Iwamoto Y; Ladanyi M; Tsuneyoshi M Oncogene; 2004 Nov; 23(53):8629-38. PubMed ID: 15467754 [TBL] [Abstract][Full Text] [Related]
4. Expression of the ETS transcription factor ELF3 in the retinal pigment epithelium. Jobling AI; Fang Z; Koleski D; Tymms MJ Invest Ophthalmol Vis Sci; 2002 Nov; 43(11):3530-7. PubMed ID: 12407165 [TBL] [Abstract][Full Text] [Related]
5. Transcriptional control of tight junction proteins via a protein kinase C signal pathway in human telomerase reverse transcriptase-transfected human pancreatic duct epithelial cells. Yamaguchi H; Kojima T; Ito T; Kimura Y; Imamura M; Son S; Koizumi J; Murata M; Nagayama M; Nobuoka T; Tanaka S; Hirata K; Sawada N Am J Pathol; 2010 Aug; 177(2):698-712. PubMed ID: 20566751 [TBL] [Abstract][Full Text] [Related]
6. Aberrant expression of tight junction-related proteins ZO-1, claudin-1 and occludin in synovial sarcoma: an immunohistochemical study with ultrastructural correlation. Billings SD; Walsh SV; Fisher C; Nusrat A; Weiss SW; Folpe AL Mod Pathol; 2004 Feb; 17(2):141-9. PubMed ID: 14704716 [TBL] [Abstract][Full Text] [Related]
7. Strong association of SYT-SSX fusion type and morphologic epithelial differentiation in synovial sarcoma. Antonescu CR; Kawai A; Leung DH; Lonardo F; Woodruff JM; Healey JH; Ladanyi M Diagn Mol Pathol; 2000 Mar; 9(1):1-8. PubMed ID: 10718206 [TBL] [Abstract][Full Text] [Related]
8. Differential Ki67 and bcl-2 immunoexpression in solid-glandular and spindle cell components of biphasic synovial sarcoma: a double immunostaining assessment with cytokeratin and vimentin. Lopes JM; Nesland JM; Reis-Filho JS; Holm R Histopathology; 2002 May; 40(5):464-71. PubMed ID: 12010367 [TBL] [Abstract][Full Text] [Related]
9. Unique and selective effects of five Ets family members, Elf3, Ets1, Ets2, PEA3, and PU.1, on the promoter of the type II transforming growth factor-beta receptor gene. Kopp JL; Wilder PJ; Desler M; Kim JH; Hou J; Nowling T; Rizzino A J Biol Chem; 2004 May; 279(19):19407-20. PubMed ID: 14976186 [TBL] [Abstract][Full Text] [Related]
10. Different domains of the transcription factor ELF3 are required in a promoter-specific manner and multiple domains control its binding to DNA. Kopp JL; Wilder PJ; Desler M; Kinarsky L; Rizzino A J Biol Chem; 2007 Feb; 282(5):3027-41. PubMed ID: 17148437 [TBL] [Abstract][Full Text] [Related]
11. A novel epithelial-expressed ETS gene, ELF3: human and murine cDNA sequences, murine genomic organization, human mapping to 1q32.2 and expression in tissues and cancer. Tymms MJ; Ng AY; Thomas RS; Schutte BC; Zhou J; Eyre HJ; Sutherland GR; Seth A; Rosenberg M; Papas T; Debouck C; Kola I Oncogene; 1997 Nov; 15(20):2449-62. PubMed ID: 9395241 [TBL] [Abstract][Full Text] [Related]
12. Transactivation of lung lysozyme expression by Ets family member ESE-1. Lei W; Jaramillo RJ; Harrod KS Am J Physiol Lung Cell Mol Physiol; 2007 Nov; 293(5):L1359-68. PubMed ID: 17905856 [TBL] [Abstract][Full Text] [Related]
13. Identification of syt-ssx fusion transcripts in both epithelial and spindle cell components of biphasic synovial sarcoma in small tissue samples isolated by membrane-based laser microdissection. Nishio J; Iwasaki H; Ishiguro M; Ohjimi Y; Isayama T; Naito M; Kikuchi M Virchows Arch; 2001 Aug; 439(2):152-7. PubMed ID: 11561755 [TBL] [Abstract][Full Text] [Related]
14. Genomic organization of the human ELF3 (ESE-1/ESX) gene, a member of the Ets transcription factor family, and identification of a functional promoter. Oettgen P; Barcinski M; Boltax J; Stolt P; Akbarali Y; Libermann TA Genomics; 1999 Feb; 55(3):358-62. PubMed ID: 10049594 [TBL] [Abstract][Full Text] [Related]
15. E-cadherin gene mutations frequently occur in synovial sarcoma as a determinant of histological features. Saito T; Oda Y; Sugimachi K; Kawaguchi K; Tamiya S; Tanaka K; Matsuda S; Sakamoto A; Iwamoto Y; Tsuneyoshi M Am J Pathol; 2001 Dec; 159(6):2117-24. PubMed ID: 11733362 [TBL] [Abstract][Full Text] [Related]
16. Responses to the proinflammatory cytokines interleukin-1 and tumor necrosis factor alpha in cells derived from rheumatoid synovium and other joint tissues involve nuclear factor kappaB-mediated induction of the Ets transcription factor ESE-1. Grall F; Gu X; Tan L; Cho JY; Inan MS; Pettit AR; Thamrongsak U; Choy BK; Manning C; Akbarali Y; Zerbini L; Rudders S; Goldring SR; Gravallese EM; Oettgen P; Goldring MB; Libermann TA Arthritis Rheum; 2003 May; 48(5):1249-60. PubMed ID: 12746898 [TBL] [Abstract][Full Text] [Related]
17. Synovial sarcoma. Inter-relationship of the biphasic and monophasic subtypes. Dardick I; Ramjohn S; Thomas MJ; Jeans D; Hammar SP Pathol Res Pract; 1991 Sep; 187(7):871-85. PubMed ID: 1661412 [TBL] [Abstract][Full Text] [Related]
18. Dysadherin expression as a significant prognostic factor and as a determinant of histologic features in synovial sarcoma: special reference to its inverse relationship with E-cadherin expression. Izumi T; Oda Y; Hasegawa T; Nakanishi Y; Kawai A; Sonobe H; Takahira T; Kobayashi C; Yamamoto H; Tamiya S; Hirohashi S; Iwamoto Y; Tsuneyoshi M Am J Surg Pathol; 2007 Jan; 31(1):85-94. PubMed ID: 17197923 [TBL] [Abstract][Full Text] [Related]
19. ELF3 is a negative regulator of epithelial-mesenchymal transition in ovarian cancer cells. Yeung TL; Leung CS; Wong KK; Gutierrez-Hartmann A; Kwong J; Gershenson DM; Mok SC Oncotarget; 2017 Mar; 8(10):16951-16963. PubMed ID: 28199976 [TBL] [Abstract][Full Text] [Related]
20. Crystal structure of mouse Elf3 C-terminal DNA-binding domain in complex with type II TGF-beta receptor promoter DNA. Agarkar VB; Babayeva ND; Wilder PJ; Rizzino A; Tahirov TH J Mol Biol; 2010 Mar; 397(1):278-89. PubMed ID: 20079749 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]